A Curated Weekly Update of All Statin Publication – Week 42, 2020

Statin use associated with impressive improvements in
NAFLD/NASH scores

NAFLD/NASH are recognized as an important global health care challenge. Prevalence in general populations has increased alarmingly in both developed- and developing economies. In the US, it is estimated that NAFLD affects 30-40% of the population, and in Indonesia, NAFLD has increased from 7.9% to 51% over the last 10-years. In this study, conducted in Greek military personnel during their annual medical check-up, both prevalence and the effects of three different statins were evaluated. Overall, 5400 soldiers participated in the initial screening. NAFLD/NASH was diagnosed in 613 participants. Patients were randomized to 4 treatment arms: diet-exercise, atorvastatin, rosuvastatin, and pitavastatin…